- Ownership
- Activity
GSK Stock Ownership Activity
GLAXOSMITHKLINE PLC-SPON ADR 13F holders
No value investing guru has made any change to the GLAXOSMITHKLINE PLC-SPON ADR (GSK) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying GSK now?
According to the latest SEC filing(s) GLAXOSMITHKLINE PLC-SPON ADR (GSK) has not been purchased by any super investor.
To see more about who is investing in GLAXOSMITHKLINE PLC-SPON ADR (GSK), please go to the GSK ownership page.
2016 Q2
(3 results)
AVG reported price*: $54.18
2016 Q1
(3 results)
AVG reported price*: $51.67
2015 Q4
(3 results)
AVG reported price*: $50.44
2015 Q3
(3 results)
AVG reported price*: $48.06
2015 Q2
(2 results)
AVG reported price*: $52.06
2015 Q1
(3 results)
AVG reported price*: $57.69
2014 Q4
(1 result)
Reported price*: $53.43
2014 Q3
(2 results)
AVG reported price*: $57.46
2014 Q2
(1 result)
Reported price*: $66.85
2014 Q1
(1 result)
Reported price*: $66.79
2013 Q4
(3 results)
AVG reported price*: $49.96
2013 Q3
(2 results)
AVG reported price*: $62.71
2013 Q2
(2 results)
AVG reported price*: $62.46
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.